Related Experiment Video
Updated: Apr 25, 2026

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
Published on: January 22, 2019
SOCS6 is a selective suppressor of receptor tyrosine kinase signaling
Nuzhat N Kabir1, Jianmin Sun, Lars Rönnstrand
1Laboratory of Computational Biochemistry, KN Biomedical Research Institute, Barisal, Bangladesh.
Abstract:
The suppressors of cytokine signaling (SOCS) are well-known negative regulators of cytokine receptor signaling. SOCS6 is one of eight members of the SOCS family of proteins. Similar to other SOCS proteins, SOCS6 consists of an uncharacterized extended N-terminal region followed by an SH2 domain and a SOCS box. Unlike other SOCS proteins, SOCS6 is mainly involved in negative regulation of receptor tyrosine kinase signaling. SOCS6 is widely expressed in many tissues and is found to be downregulated in many cancers including colorectal cancer, gastric cancer, lung cancer, ovarian cancer, stomach cancer, thyroid cancer, hepatocellular carcinoma, and pancreatic cancer. SOCS6 is involved in negative regulation of receptor signaling by increasing degradation mediated by ubiquitination of receptors or substrate proteins and induces apoptosis by targeting mitochondrial proteins. Therefore, SOCS6 turns out as an important regulator of survival signaling and its activity is required for controlling receptor tyrosine kinase signaling.
Insights
Suppressors of cytokine signaling 6 (SOCS6) negatively regulates receptor tyrosine kinase signaling by promoting protein degradation and apoptosis. SOCS6 downregulation in cancers highlights its role in survival signaling.
Area of Science:
- Molecular Biology
- Oncology
- Cell Signaling
Background:
- Suppressors of cytokine signaling (SOCS) proteins are key negative regulators of cytokine receptor signaling.
- SOCS6, a member of the SOCS family, uniquely targets receptor tyrosine kinase signaling pathways.
- SOCS6 protein structure includes an N-terminal region, SH2 domain, and SOCS box.
Purpose of the Study:
- To elucidate the specific role of SOCS6 in receptor tyrosine kinase signaling.
- To investigate the mechanisms by which SOCS6 regulates cell survival and apoptosis.
- To examine the implications of SOCS6 downregulation in various human cancers.
Main Methods:
- Analysis of SOCS6 expression patterns in different tissues and cancer types.
- Investigation of SOCS6's role in protein ubiquitination and degradation pathways.
- Assessment of SOCS6's impact on apoptosis induction via mitochondrial pathways.
Main Results:
- SOCS6 is widely expressed but downregulated in numerous cancers, including colorectal, gastric, and lung cancer.
- SOCS6 mediates negative regulation of receptor signaling through enhanced ubiquitination and degradation of receptors and substrates.
- SOCS6 induces apoptosis by targeting mitochondrial proteins, thus acting as a regulator of survival signaling.
Conclusions:
- SOCS6 is a critical negative regulator of receptor tyrosine kinase signaling.
- SOCS6's tumor-suppressive activity is linked to its role in promoting protein degradation and apoptosis.
- Restoring SOCS6 activity may offer therapeutic potential for various cancers characterized by its downregulation.
More Related Videos
Related Concept Videos
The JAK-STAT Signaling Pathway
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
TGF - β Signaling Pathway
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Amplifying Signals via Enzymatic Cascade
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...

